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Improper clearance of dying cells by activated neighboring phagocytes contributes to the establishment and progres-
sion of numerous human diseases. As a consequence, effero-
cytosis-dependent efficient repair is critical to sustain tissue 
homeostasis by directing the healing of injured tissues through 
active removal of apoptotic or necrotic cells out of the milieu.1
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Cellular necrosis and apoptosis in the acute inflammatory 
phase of myocardial infarction (MI) are integral components 
of tissue remodeling and should be dealt with appropriately 
to improve tissue healing and recovery.2,3 The externalization 
of phosphatidylserine on the outer leaflet of the injured cell 
membrane is one of the earliest signals sufficient to activate 
the phagocytotic process. The recognition of cells exposing 
phosphatidylserine is mediated by a few receptors, among 
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which myeloid-epithelial-reproductive receptor tyrosine 
kinase (Mertk) and milk fat globule epidermal growth factor–
like factor 8 (Mfge8) are upregulated during inflammation 
and play nonredundant roles. Mertk receptor on phagocytes 
recognizes apoptotic cells by bridging Gas6 and protein S, 
which directly interact with phosphatidylserine.4,5 Mfge8 is 
a secretory glycoprotein containing C domains that interact 
with anionic phospholipids and extracellular matrixes, as well 
as epidermal growth factor–like domains with an RGD motif 
that binds integrin α
v
β3 and αvβ5.6 Thus, Mfge8 appears to be 
instrumental in cell-cell interactions and has been involved 
in diverse physiological functions, including fertilization,7 
angiogenesis,8 atherosclerosis,9 or innate immunity, through 
inhibition of inflammasome-induced interleukin (IL)-1β pro-
duction.10 One of the prominent functions of Mfge8 is also 
to link phosphatidylserine of dying cells to integrin α
v
β3 
and α
v
β5 of phagocytic cells.11–13 Although the clearance of 
apoptotic debris by Mertk and Mfge8 has been characterized 
independently in different pathological settings, whether they 
also coordinate their functions has not been explored yet. We 
hypothesized that Mertk and Mfge8 play a critical role in syn-
chronizing efferocytosis within the cardiac tissue after MI and 
subsequently orchestrate cardiac remodeling.
During the inflammatory reaction, 2 sequential phases 
defined by the expression of Ly6C on monocytes/macrophages 
can be identified in the infarcted myocardium.14,15 The inflam-
matory Ly-6CHigh monocyte subset is recruited during the first 
days after MI, but their number is reduced from day 5 onward, 
when inflammation resolves in the cardiac wound. Starting at 
approximately day 3 after MI, the infarct tissue accumulates 
Ly-6CInt/Low monocytes. The inflammatory Ly-6CHigh monocyte 
subset can drive robust inflammation, leading to pathologi-
cal remodeling, whereas Ly-6CInt/Low monocytes/macrophages 
seem to promote reparative activities, including angiogen-
esis.14,15 However, both monocyte subsets are required for ade-
quate cardiac repair because ablation of each subpopulation 
is sufficient to disturb the healing process.14 Many of these 
monocytes may either die or exit the cardiac tissue, whereas 
surviving monocytes populating the ischemic milieu may 
acquire a macrophage phenotype with M1- or M2-like activa-
tion mode associated with specific functions in the resolution 
of inflammation, tissue repair, and remodeling.16 Recent works 
also indicate that the adult heart expands distinct populations 
of macrophages, including monocyte-derived macrophages 
and subsets of resident macrophages of embryonic origin, 
with opposite roles in inflammation and cardiac recovery.17–20
How different subsets of monocytes/macrophages can 
govern distinct patterns of cardiac recovery remains largely 
unknown. Interestingly, efferocytosis can operate a shift in 
macrophage activation toward M2-like cells.21 Along this line, 
dying tumor cells that are cleared through Mertk-dependent 
efferocytosis robustly induce the transcription of genes encod-
ing wound-healing cytokines, including IL-4, IL-10, IL-13, 
and transforming growth factor-β (TGFβ).22
We reasoned that efficient Mertk- or Mfge8-dependent 
clearance of dying cardiac cells by tissue monocytes/macro-
phages dictates their phenotype and is required to fine-tune 
the reparative process after ischemic cardiac injury. Here, we 
show that efferocytosis-related signaling commands vascular 
endothelial growth factor (VEGF) A release by monocytes/
macrophages and limits adverse left ventricular remodeling 
after MI.
Methods
Animals
C57Bl/6J Rj (wild-type [WT]; Janvier Labs, St. Berthevin, France), 
Mertk−/−, Mfge8−/−, and Mertk−/−/Mfge8−/− mice were 8 to 12 weeks 
old. Mertk−/−, Mfge8−/−, and Mertk−/−/Mfge8−/− mice were on C57Bl/6J 
background.8,23 CD45.1 (Ly5.1) C57Bl/6 mice were purchased from 
Charles River Labs (France). LysMCre+/VEGFfl/fl and LysMCre−/
VEGFfl/fl were provided by Dr C. Stockmann.24 Cardiac α-actin–
green fluorescent protein (α-actin–GFP+) mice on C57Bl/6J back-
ground were provided by B.K. Fleischmann.25 All experiments were 
conducted according to the French veterinary guidelines and the 
European community for experimental animal use and were approved 
by the Institut National de la Santé et de la Recherche Médicale.
Myocardial Infarction
Mice were anesthetized with ketamine (100 mg/kg) and xylazine 
(10 mg/kg) via intraperitoneal injection and then intubated and ven-
tilated with air with a small-animal respirator (Harvard Apparatus, 
Courtaboeuf, France). The chest wall was shaved, and a thora-
cotomy was performed in the fourth left intercostal space. The 
left ventricle was visualized; the pericardium was then removed; 
and the left anterior descending artery was permanently ligated 
with a 7-0 monofilament suture (Peters Surgical, Bobigny, France) 
at the site of its emergence from under the left atrium, as previ-
ously described.26,27 Significant blanching at the ischemic area was 
considered indicative of successful coronary occlusion. The thora-
cotomy was closed with four 6-0 monofilament sutures. The endo-
tracheal tube was removed once spontaneous respiration resumed, 
and animals were placed on a warm pad maintained at 37°C until 
they were completely awake.
Bone Marrow Transplantation
Bone marrow (BM) cells were obtained by flushing tibiae and femora 
of donor mice, as described above. WT mice were lethally irradiated 
with a total dose of 9.5 Gy and were intravenously injected 24 hours 
later with 1×107 total BM cells from WT, Mertk−/−, Mfge8−/−, Mertk−/−/
Mfge8−/−, LysMCre−/VEGFfl/f, or LysMCre+/VEGFfl/fl cells. Mice 
were then challenged with MI 10 weeks after BM reconstitution.
Echocardiography
The left ventricular function was assessed by transthoracic echo-
cardiography with a VEVO2100 Biomicroscope (Visualsonics). 
Mice were anesthetized with isoflurane (1.5% in air), shaved 
with the use of depilatory cream, and placed on a dedicated eat-
ing plate in the supine position, allowing monitoring of respira-
tory frequency and temperature. Parasternal long-axis views of 
the left ventricle were obtained with a 40-MHz ultrasound probe 
(MS550D) at a frame rate between 180 and 240 frames per second. 
Measurements were performed offline with the Advanced Cardio 
Package of the VEVO2100 software. Endocardium contours were 
drawn from telesystolic and telediastolic long-axis views; left ven-
tricular end-diastolic and -systolic volumes and ejection fraction 
were then measured.
Immunohistochemical Analysis
Fourteen days after MI, hearts were perfused with PBS. Left ven-
tricles were mounted in Cryomatrix (Thermo Scientific) and dropped 
into frozen isopentane. Sections (7 μm) were cut. For evaluation of 
apoptosis, heart sections were stained with terminal deoxynucleo-
tidyl transferase dUTP nick-end labeling technology kit (Roche 
Diagnostics, Meylan, France) according to the manufacturer’s 
instructions. Masson trichrome and Red Sirius stainings were 
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performed to analyze infarct size and collagen content, respectively. 
Infarct size was expressed as the ratio of endocardial left ventricular 
scar length to the total endocardial left ventricular length. Collagen 
content and the number of capillaries were quantified in the border 
zone of the infarct scar on a Axioimager Carl Zeiss microscope. 
Collagen content was measured as the ratio of the total area stained 
by Red Sirius to the total area of the tissue section on the Image J 
software. Capillaries were stained with TRITC-conjugated Griffonia 
simplicifolia lectin (Sigma-Aldrich, Evry, France) and cardiomyo-
cyte membranes with FITC-conjugated wheat germ agglutinin lectin 
(Sigma-Aldrich). Results were expressed as the ratio of capillaries 
number to cardiomyocytes.
Immunohistochemical VEGFA Staining on 
Macrophages
Five days after MI, hearts were perfused with PBS. Left ventricles 
were mounted in Cryomatrix (Thermo Scientific) and dropped into 
frozen isopentane. Sections (7 μm) were cut. Heart sections were 
fixed with 4% paraformaldehyde for 10 minutes at room tempera-
ture, stained with TRITC-conjugated wheat germ agglutinin lectin for 
1 hour at room temperature, washed with PBS, permeabilized with 
0.25% Triton X100 in PBS, washed with PBS, blocked for 30 min-
utes at room temperature in 5% donkey serum in PBS, stained 2 hours 
at room temperature with anti-VEGFA (Abcam, Cambridge, Great 
Britain), washed with PBS, stained 1 hour at room temperature with 
FITC donkey anti-rabbit IgG, washed with PBS, stained overnight 
with anti-CD68 (AbD Serotec, Bio-Rad, Kidlington, Oxford, UK) at 
4°C, washed with PBS, and stained with Cy5 donkey anti-rat IgG 
for 1 hour at room temperature. Slides were mounted with DAPI and 
Mowiol. Images were acquired on a Leica SP8 confocal microscope.
Injection of BM Mononuclear Cells
BM cells were obtained by flushing tibiae and femora of donor mice. 
Low-density BM-derived mononuclear cells were then isolated by 
density gradient centrifugation with Ficoll (Histopaque-1083, Sigma-
Aldrich). BM mononuclear cells from WT, Mertk−/−, Mfge8−/−, or 
Mertk−/−/Mfge8−/− were injected 24 hours after MI in WT mice.
Cardiac Efferocytosis
To unravel in vivo cardiac efferocytosis, cardiac α-actin–GFP mice with 
constitutive expression of GFP in cardiomyocytes were lethally irradi-
ated with a total dose of 9.5 Gy and intravenously injected 24 hours 
later with 1×107 total BM cells isolated from WT or double-knockout 
Mertk−/−/Mfge8−/− animals. MI was induced 10 weeks after BM recon-
stitution. Three days after MI, cardiac mononuclear cells were isolated 
as described above and stained. Events were acquired on ImageStream 
(Amnis Corp) and analyzed on Ideas software. The amount of effero-
cytosis was determined as the percentage of GFP-positive cells among 
the population of Ly6CHigh/Low monocytes/macrophages.
Flow Cytometry Analysis
At 1, 3, 5, 7, and 10 days after MI, hearts were perfused with PBS. 
Left ventricles were harvested; minced with fine scissors; placed into 
a cocktail of collagenase I (450 U/mL), collagenase XI (125 U/mL), 
DNase I (60 U U/mL), and hyaluronidase (60 U/mL; Sigma-Aldrich); 
and shaken at 37°C for 1 hour, as previously described.27 Cells were 
then triturated through a nylon mesh (40 μm) and centrifuged (10 
minutes, 400g, 4°C). Mononuclear cells were purified by density cen-
trifugation with Ficoll (Histopaque-1083, Sigma-Aldrich; 25 minutes, 
400g, room temperature). The resulting cell suspensions were washed 
with PBS, and total leukocyte numbers were determined. Cells har-
vested from the hearts were stained in PBS at 4°C with the following 
antibodies: efluor450-conjugated anti-CD11b (M1/70, Biolegend), 
phycoerythrin-conjugated anti-Ly6G (1A8, BD Pharmingen, Le 
Pont de Claix, France), phycoerythrin-conjugated anti–NK-1.1 
(PK 136, BD Pharmingen), alexa488-conjugated anti-F4/80 (AbD 
Serotec, Bio-Rad, Kidlington), APC-Cy7–conjugated anti-Ly6C 
(BD Biosciences, Le Pont de Claix, France), Percp-conjugated 
anti-CD45 (BD Biosciences), PeAlexa700-conjugated anti-CD45.2, 
and Percp-conjugated anti-CD45.1 (A20, BD Pharmingen). All anti-
bodies were used at a dilution of 1:100. Monocytes were identified 
as CD11b+F4/80−Ly6G−Ly6CHigh or Low. Neutrophils were identified 
as CD11b+Ly6GHighF480−Ly6CInt. Macrophages were identified as 
CD11b+Ly6G− F480+Ly6CHigh or Low. The total number of cells was then 
normalized to heart weight. Events were acquired on an LSR II flow 
cytometer (BD Biosciences), and results were analyzed on FlowJo 
(FlowJo LLC, Ashland, OR).
Protein Expression of Chemokines, Cytokines, and 
Growth Factors in the Cardiac Tissue 
At 1, 3, 5, 7, and 10 days after MI, the upper part of the left ven-
tricle was harvested and homogenized in Tris EDTA NaCl buffer (1 
mmol/L EDTA, 10 mmol/L Tris-HCl, pH 7.5, 150 mmol/L NaCl, 
10 mg/mL NP40 with antiprotease cocktail; Roche Diagnostics, 
Meylan, France). Protein concentration was assessed by Lowry assay, 
and sample concentrations were normalized before quantification of 
proteins. CCL2, CCL7, IL-1β, IL-6, IL-10, IL-12, IL-13, and tumor 
necrosis factor-α were quantified with Flowcytomix (ebiosciences, 
Paris, France) according to the manufacturer’s instructions. VEGFA 
and TGFβ were quantified by ELISA (R&D Systems Europe, Lille, 
France) according to the manufacturer’s instructions.
In Vitro Generation of BM-Derived Macrophages
BM cells were flushed from tibias and femora, washed in PBS with 
1% FBS, and cultured in macrophage growth medium for 7 days 
(RPMI 1640 Glutamax, Fisher Scientific, Illkirsh, France) supple-
mented with 10% heat-inactivated FCS, 15% L929 medium, and 100 
U/mL penicillin/streptomycin. Macrophages were then activated for 
an additional 24 hours with 1 μg/mL lipopolysaccharide (LPS) and 
100 U/mL interferon-γ (IFNγ), 10 ng/mL IL-4, or 10 ng/mL IL-10 
(R&D Systems Europe). After 24 hours, the medium was removed, 
and RPMI 1640 Glutamax supplemented with 10% FCS and 100 U/
mL penicillin/streptomycin (complete RPMI medium) was added for 
24 hours. Supernatants were harvested for ELISA assays, and cells 
were washed 3 times in cold PBS and resuspended in RNeasy Lysis 
Buffer (Rneasy Micro Kit, Qiagen, Courtaboeuf, France). RNA was 
extracted according to the manufacturer’s instructions.
In Vivo Phagocytosis Assay
Phagocytosis by inflammatory macrophages was evaluated by inject-
ing 1×107 apoptotic thymocytes or PBS alone (control without 
phagocytosis) 72 hours after the initial peritoneal injection of thio-
glycolate (3%; BBL Thioglycolate Medium, brewer modified, BD 
Biosciences). Three hours after injection, 1 mL PBS was injected 
into the peritoneum and collected. Peritoneal lavage fluid was centri-
fuged. Supernatants were harvested and frozen before VEGFA quan-
tification. To evaluate the amount of efferocytosis by flow cytometry, 
cells were collected and stained with the following antibodies: Alexa 
488–conjugated anti-CD11b and V450-conjugated anti-Ly6G (BD 
Biosciences). The amount of efferocytosis by monocytes/macro-
phages was expressed as arbitrary fluorescence unit.
Statistical Analysis
Results are expressed as mean±SEM. Kruskal-Wallis 1-way ANOVA 
was used to compare each measure when there were ≥3 independent 
groups. Comparisons between groups were performed with Dunn 
multiple-comparisons test when the ANOVA test was statistically 
significant. A value of P<0.05 was considered significant. The Mann–
Whitney test was used to compare 2 groups.
Results
Mertk and Mfge8 Coordinately Improve Cardiac 
Remodeling After MI
To decipher the respective roles of the 2 major phagocytic 
proteins Mertk and Mfge8 in cardiac homeostasis, we used 
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mice deficient for Mertk (Mertk−/−), Mfge8 (Mfge8−/−), or both 
(Mertk−/−/Mfge8−/−) and challenged them with coronary artery 
ligature to induce acute MI. Mice lacking both Mertk and Mfge8 
showed a clear defective cardiac phenotype compared with WT 
mice, with an intermediate phenotype in the single-knockout 
(Mertk−/− or Mfge8−/−) animals (Figure 1). Notably, ejection frac-
tion was smaller whereas left ventricular end-systolic and -dia-
stolic volumes were higher in Mertk−/−/Mfge8−/− mice compared 
with WT animals (Figure 1A). Alteration in cardiac function was 
associated with adverse left ventricular remodeling. Along this 
line, infarct size and collagen content were greater by 1.5- and 
1.9-fold, respectively, in Mertk−/−/Mfge8−/− mice compared with 
WT animals (Figure 1B). Furthermore, the number of apoptotic 
cells was 2-fold higher in Mertk−/−/Mfge8−/− mice compared with 
WT animals (P<0.01). The number of capillaries also tended to 
be lower in Mertk−/−/Mfge8−/− animals compared with WT mice 
(P<0.05, Mann–Whitney U test; Figure 1B).
Together, these data indicate a central cooperative role for 
Mertk- and Mfge8-dependent signaling in the control of car-
diac remodeling and the recovery of heart function after MI.
Myeloid-Derived Mertk and Mfge8 Improve 
Remodeling After MI
Because professional phagocytes mainly express Mertk and 
Mgfe8, we first identified the type of inflammatory cells 
expressing these proteins in the infarcted heart. Using cells 
sorted by fluorescence-activated cell sorter, we showed that 
Mertk and Mfge8 mRNA levels were detected mainly in car-
diac Ly6CHigh and Ly6CLow monocytes/macrophages (CD45+/
CD11b+/Ly6G−) and in F4/80-positive macrophages (CD45+/
CD11b+/Ly6G−/Ly6C+). Low Mertk and Mfge8 expression was 
also noticed in infiltrated neutrophils (CD45+/CD11b+/Ly6G+). 
In contrast, T lymphocytes (CD45+/CD3+) did not express 
these phagocytic proteins (Figure 2A). We next explored the 
impact of Mertk and Mfge8 in BM-derived cells using lethally 
irradiated WT mice transplanted with BM isolated from WT, 
Mertk−/−, Mfge8−/−, or Mertk−/−/Mfge8−/− mice (Figure 2B and 
2C) and subjected to acute MI. Fourteen days after the onset of 
MI, ejection fraction was lower but left ventricular systolic and 
diastolic volumes were higher in Mertk−/−Mfge8−/− BM com-
pared with WT BM (P<0.001; Figure 2B). Reconstitution with 
BM from Mertk−/− or Mfge8−/− mice resulted in intermediate 
effects on cardiac remodeling and heart function (Figure 2).
Infarct size, collagen content, and the number of apoptotic 
cells were 1.6-, 1.4-, and 2.2-fold higher, respectively, in WT 
mice transplanted with Mertk−/−Mfge8−/− BM compared with 
those receiving WT BM (P<0.001; Figure 2C). In addition, cap-
illary density tended to be lower in Mertk−/−Mfge8−/− BM chi-
meras (P<0.05, Mann–Whitney U test; Figure 2C). Our results 
were confirmed by a second set of experiments in which WT 
mice received intravenous injection of 1×106 BM isolated from 
WT, Mertk−/−, Mfge8−/−, or Mertk−/−/Mfge8−/− animals 24 hours 
after the onset of ischemia (Figure I in the online-only Data 
Supplement). Together, these results support a crucial role for 
Mertk and Mfge8 in BM-related effects in the infarcted heart.
We next sought to understand the mechanisms underly-
ing the influence of myeloid-derived Mertk and Mfge8 in car-
diac remodeling after MI, focusing on the double-deficiency 
context.
We first assessed the extent of efferocytosis of dead cardio-
myocytes in the infarcted heart using transgenic mice, in which 
expression of GFP is under control of the cardiac α-actin 
promoter (α-actin–GFP+).25 Using ImageStream assays, we 
observed that the efferocytosis of dying GFP+ cardiomyocytes 
was significantly lower in the absence of Mertk and Mfge8, as 
revealed by the marked decrease in the number of cardiac GFP+ 
Ly6C+ monocytes/macrophages (CD45+/CD11b+/Ly6G−) iso-
lated from lethally irradiated α-actin–GFP+ mice transplanted 
with Mertk−/−/Mfge8−/− BM compared with those transplanted 
with WT BM 3 days after the onset of MI (Figure 3A).
We then examined whether abrogation of Mertk and Mfge8 
signaling might have altered the ability of inflammatory cells 
to infiltrate the ischemic milieu. To evaluate the number of 
infiltrating cells, 1×107 mononuclear cells isolated from the 
BM of CD45.2 WT and Mertk−/−/Mfge8−/− animals were intra-
venously injected into WT CD45.1 mice 6 hours after MI. One 
day after the injection, we found that the numbers of CD45.2 
BM mononuclear cells isolated from WT or Mertk−/−/Mfge8−/− 
animals were similar in CD45.1 infarcted hearts (Figure IIA 
in the online-only Data Supplement). Along this line, the pro-
tein levels of 2 major chemokines, Ccl7 and Ccl2, involved 
in the recruitment of circulating CCR2-positive inflammatory 
cells,26,28 were not affected in WT mice lethally irradiated and 
transplanted with WT or Mertk−/−/Mfge8−/− BM (Figure IIB 
in the online-only Data Supplement). Hence, alteration of the 
efficiency of efferocytosis was not related to changes in the 
number of infiltrated circulating inflammatory cells.
We next hypothesized that a reduction in efferocytosis 
and a subsequent increase in apoptotic cell number may have 
altered the number of specific subpopulations of inflamma-
tory cells in the myocardium: cardiac neutrophils and cardiac 
monocytes/macrophages, which are major players in the set-
ting of MI. Using fluorescence-activated cell sorter analysis 
of cardiac tissue, we demonstrated that the number of neutro-
phils was unchanged between WT mice lethally irradiated and 
transplanted with Mertk−/−/Mfge8−/− BM and those transplanted 
with WT BM (Figure 3B). In the mouse, circulating monocytes 
are phenotypically and functionally heterogeneous and can be 
separated according to Ly6C expression.29,30 We showed that the 
number of cardiac Ly6CHigh and Ly6CLow monocytes (CD45+/
CD11b+/Ly6G−) was similar in WT mice lethally irradiated and 
transplanted with Mertk−/−/Mfge8−/− BM compared with those 
transplanted with WT BM (Figure 3B). Transient accumulation 
of Ly6CHigh monocytes in the infarcted heart gives rise to distinct 
population of F4/80-expressing macrophages.31 However, as 
for the monocytes subsets, the amount of Ly6CHigh and Ly6CLow 
macrophages (CD45+/CD11b+/Ly6G−/F4/80+) was not differ-
ent between the 2 groups of mice regardless of the time point 
after the induction of MI (Figure 3B). Among macrophages, 
embryo-derived tissue resident macrophages are crucial to car-
diac remodeling.17–20 Those cells are characterized mainly by 
F4/80+ CCR2− staining in contrast to monocyte-derived macro-
phages, which are characterized mainly by F4/80+ CCR2+. We 
quantified the number of CCR2−MHCIIHigh and MHCIILow mac-
rophages in hearts from WT mice lethally irradiated and trans-
planted with Mertk−/−/Mfge8−/− BM and those transplanted with 
WT BM 7 days after MI. First, the number of CCR2−MHCIILow 
and MHCIIHigh macrophages is 10 times lower than that of 
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CCR2+ MHCII cells. Second, the number of CCR2−MHCIILow 
and MHCIIHigh macrophages was similar in WT mice lethally 
irradiated and transplanted with Mertk−/−/Mfge8−/− BM and those 
transplanted with WT BM (Figure IIIA in the online-only Data 
Supplement). Furthermore, to track the origin of macrophages 
in our experimental conditions, we performed total body irra-
diation on CD45.1 mice and then transplanted mice with either 
CD45.2 WT BM or CD45.2 Mertk−/−Mfge8−/− BM. After BM 
reconstitution, we performed MI and assessed CD45.1- and 
CD45.2-positive macrophages number by flow cytometry. Seven 
days after MI, <2% of F4/80-positive cells were CD45.1 posi-
tive, supporting the statement that the vast majority of cardiac 
macrophages are not embryo derived in our specific experimen-
tal conditions (Figure IIIB in the online-only Data Supplement).
The function of myeloid cells changes over time. Early after 
the onset of ischemia, the tissue is highly inflammatory, and 
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Figure 1. Cardiac healing is impaired in Mertk−/−/Mfge8−/− mice. A, Echocardiographic analysis 14 days after myocardial infarction. 
Ejection fraction (%), left ventricular end-diastolic volume (μL), and left ventricular end-systolic volume (μL) are shown for wild-type (WT), 
Mertk−/−, Mfge8−/−, and Mertk−/−/Mfge8−/− mice. Results are minimum to maximum values. n=6 mice per group. *P<0.05, **P<0.01 vs WT 
mice (Kruskal-Wallis 1-way ANOVA). B, Quantitative analysis of infarct size, collagen content, capillary density, and number of apoptotic 
cells. Results are presented as scatterplots with mean bar. n=6 mice per group. *P<0.05, **P<0.01 vs WT mice (Kruskal-Wallis 1-way 
ANOVA). Representative photomicrographs are shown. Arrows point to area of interest. Bar, 100 μm. Mertk indicates myeloid-epithelial-
reproductive protein tyrosine kinase; Mfge8, milk fat globule epidermal growth factor; Tunel, terminal deoxynucleotidyl transferase dUTP 
nick-end labeling; and WGA, wheat germ agglutinin.
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Ly-6CHigh monocytes and macrophages in an M1-like activation 
mode release high amounts of inflammatory cytokines and pro-
teases. During the following rebuilding phase, the inflammatory 
activity resolves and gives way to Ly-6CInt/Low monocytes/mac-
rophages. These cells may release VEGFA, TGFβ, and IL-10, 
supporting angiogenesis, collagen production, and inflammation 
resolution. We therefore evaluated those modulators of cardiac 
remodeling in our experimental conditions. Protein levels of 
IL-1β, IL-6, IL-12, IL-13, tumor necrosis factor-α, and TGFβ 
were unchanged in the cardiac tissue of WT mice lethally irra-
diated and transplanted with Mertk−/−/Mfge8−/− BM compared 
with those transplanted with WT BM. Interestingly, at day 3 
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Figure 2. Bone marrow (BM)–derived myeloid-epithelial-reproductive protein tyrosine kinase (Mertk) and milk fat globule epidermal 
growth factor (Mfge8) improve cardiac remodeling after myocardial infarction (MI). A, Mfge8 and Mertk mRNA levels in fluorescence-
activated cell sorter–sorted Ly6CHigh and Ly6CLow monocytes (MO)/macrophages (Mϕ; CD45+CD11b+ Ly6G− Ly6CHigh/Low), neutrophils 
(CD45+CD11b+Ly6G+), T lymphocytes (CD45+CD3+), and F4/80-positive macrophages (CD45+/CD11b+/Ly6G−/Ly6C+) isolated from wild-
type (WT) mice with MI. Cardiac tissue was harvested at day 1 (neutrophils and T lymphocytes), day 3 (Ly6CHigh and Ly6CLow monocytes/
macrophages), and day 7 (F4/80-positive macrophages) after the onset of MI. Results are mean±SEM. n=3 to 4 mice per group.  
B, Echocardiographic analysis 14 days after MI. Ejection fraction (%), left ventricular end-diastolic volume (μL), and left ventricular end-
systolic volume (μL) are shown for lethally irradiated WT mice (Host) transplanted with BM cells isolated from WT, Mertk−/−, Mfge8−/−, and 
Mertk−/−/Mfge8−/− mice. Results are minimum to maximum values. n=8 to 20 mice per group. *P<0.05, ***P<0.001 vs WT BM chimeras 
(Kruskal-Wallis 1-way ANOVA). C, Quantitative analysis of infarct size (top left), collagen content (top right), number of apoptotic cells 
(bottom left), and capillary density (bottom right). Results are presented as scatterplots with mean bar. n=8 mice per group. *P<0.05, 
**P<0.01, ***P<0.001 vs WT BM chimeras (Kruskal-Wallis 1-way ANOVA).
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Figure 3. Bone marrow (BM)–derived myeloid-epithelial-reproductive protein tyrosine kinase (Mertk) and milk fat globule epidermal 
growth factor (Mfge8) do not affect the number of cardiac monocytes/macrophages in the infarcted heart. A, Quantification of the number 
of green fluorescent protein (GFP)–positive Ly6C monocytes/macrophages (CD45+CD11b+Ly6G−Ly6CHigh/Low) by ImageStream analysis 
in the ischemic heart of α-actin–GFP+ mice transplanted with wild-type (WT) or Mertk−/−/Mfge8−/− BM cells. Representative images of 
ImageStream assay are shown. Results are mean±SEM. n=4 per group **P<0.01 vs WT chimeras (Mann–Whitney test). B, Cells harvested 
from WT mice transplanted with BM cells isolated from WT (BM WT) or Mertk−/−/Mfge8−/− (BM Mertk−/−/Mfge8−/−) mice were analyzed 
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after MI, cardiac protein levels of VEGFA (P<0.05) and IL-10 
(P=0.0556) were lower in Mertk−/−Mfge8−/− BM chimeras com-
pared with controls (Figure 4A).
From these data, we postulated that an alteration in car-
diac VEGFA and IL-10 protein levels might be related to a 
reduction in the ability of cardiac monocytes/macrophages 
to release these factors. We first showed that CD68-positive 
cells expressed VEGFA in the infarcted heart (Figure IV in the 
online-only Data Supplement). We then used fluorescence-
activated cell sorter to sort Ly6CHigh and Ly6CLow monocytes/
macrophages from hearts 3 days after infarction. Next, we 
examined VEGFA and IL-10 expression by quantitative poly-
merase chain reaction. VEGFA mRNA levels were smaller 
in sorted Ly6CHigh and Ly6CLow monocytes/macrophages 
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Figure 4. Bone marrow (BM)–derived myeloid-epithelial-reproductive protein tyrosine kinase (Mertk) and milk fat globule epidermal growth 
factor (Mfge8) govern vascular endothelial growth factor A (VEGFA) release. A, Quantitative analysis of cytokines and VEGFA protein 
levels in the cardiac tissue of lethally irradiated wild-type (WT) mice transplanted with BM-derived cells isolated from WT (BM WT) or 
Mertk−/−/Mfge8−/− (BM Mertk−/−/Mfge8−/−) animals at days 1, 3, 5, 7, and 10 after myocardial infarction. Results are mean±SEM. n=4 to 5 
mice per group. *P<0.05 vs WT BM chimeras at day 3 (Mann–Whitney test). B, VEGFA and interleukin (IL)-10 mRNA levels in Ly6CHigh and 
Ly6CLow monocytes/macrophages (CD11b+Ly6G−Ly6CHigh/Low) sorted by fluorescence-activated cell sorter from the cardiac tissue of WT 
mice transplanted with BM from WT or Mertk−/−/Mfge8−/− mice at day 3 after myocardial infarction. Results are mean±SEM. n=3 to 4 mice 
per group. *P<0.05, **P<0.01 vs WT chimeras (Mann–Whitney test). nd indicates not detected; TGFβ, transforming growth factor-β; and 
TNFα, tumor necrosis factor-α.
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collected from WT mice transplanted with Mertk−/−Mfge8−/− 
BM compared with those transplanted with WT BM. No dif-
ference was observed in IL-10 mRNA levels (Figure 4B).
In response to various signals, macrophages may balance 
between the M1- and M2- like modes. We speculated that Mertk/
Mgfe8 signaling might modulate macrophage activation state 
and their ability to release VEGFA. To examine this hypoth-
esis, macrophages were differentiated in vitro from cultured 
BM isolated from WT or Mertk−/−/Mfge8−/− animals and acti-
vated with cytokines to trigger various inflammatory profiles. 
LPS/IFNγ elicited the M1-like mode, whereas IL-4 and IL-10 
treatments induced M2-like macrophages.32 Mfge8 and Mertk 
were expressed in all types of WT BM–derived macrophages 
and were not detected in Mertk−/−/Mfge8−/− BM–derived mac-
rophages (Figure 5A). Notably, treatment with IL-4 height-
ened both Mertk and Mfge8 mRNA levels compared with 
LPS+IFNγ or IL-10 stimulation (Figure 5A). Results also 
showed that macrophage activation was achieved in these in 
vitro conditions; that is, mRNAs of the M1 markers (Cox2 and 
NOS2) were strongly expressed in WT macrophages treated 
with both LPS and IFNγ, whereas the M2 markers mRNAs 
(Ym1, Arg1, VCAM1, RELMα) were increased in WT mac-
rophages treated with IL-4. Smaller variations were observed 
among primary cultures for the expression of the M2 marker 
mRNAs in WT macrophages treated with IL-10 (Figure 5B 
and 5C). Interestingly, M1 markers were highly expressed 
in LPS+IFNγ–treated Mertk−/−/Mfge8−/− BM–derived macro-
phages compared with WT (Figure 5B). Conversely, in the 
setting of IL-4 stimulation, mRNA levels of the M2 markers 
were downregulated in Mertk−/−Mfge8−/− BM–derived macro-
phages compared with WT cells (Figure 5C). Consistent with 
this, VEGFA protein release was lower in IL-4– and IL-10–
treated Mertk−/−Mfge8−/− BM–derived macrophages compared 
with WT cells (Figure 5D).
Finally, we assessed the putative causal link between 
Mertk/Mfge8-dependent efferocytosis and VEGFA release. 
We injected 1×107 R18-labeled apoptotic thymocytes in 
WT mice lethally irradiated and transplanted with WT BM 
or Mertk−/−/Mfge8−/− BM (Figure V in the online-only Data 
Supplement). Monocytes/macrophages efficiently took up 
apoptotic thymocytes in WT mice transplanted with WT BM. 
Interestingly, efferocytosis was significantly lower in WT 
mice transplanted with Mertk−/−/Mfge8−/− BM (Figure 6A). 
Concomitantly, apoptotic cells triggered VEGFA release in 
WT mice transplanted with WT BM but not in WT mice trans-
planted with Mertk−/−/Mfge8−/− BM (Figure 6B). Moreover, 
we challenged the peritoneal lavage fluid obtained after prim-
ing with apoptotic cells for endothelial cell proliferation and 
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Figure 5. Milk fat globule epidermal growth factor (Mfge8) and myeloid-epithelial-reproductive protein tyrosine kinase (Mertk) control an 
M2-like activation mode and macrophage-derived vascular endothelial growth factor A (VEGFA) release. cDNA of bone marrow (BM)–
differentiated macrophages from wild-type (WT) or Mertk−/−/Mfge8−/− mice was analyzed by reverse transcription–quantitative polymerase 
chain reaction. A, Mertk and Mfge8 mRNA levels. Results are mean±SEM. n=4 to 5 mice per group. #P<0.5, ##P<0.001 vs interleukin 
(IL)-4–treated macrophages (Kruskal-Wallis 1-way ANOVA). B, mRNA levels for the markers of the M1-like mode: NOS2 and cox2. Results 
are mean±SEM. n=4 to 5 mice per group. C, mRNA levels for the markers of the M2-like mode: Ym1, Arg1, VCAM-1, and RELMα. Results 
are mean±SEM. n=4 to 5 mice per group. D, VEGFA protein levels were quantified in the supernatants of differentiated macrophages by 
ELISA. Results are mean±SEM. n=4 to 5 mice per group. IFNγ indicates interferon-γ; and LPS, lipopolysaccharide. B through D: *P<0.05, 
**P<0.01 vs WT of the same stimulated group of macrophages (Mann–Whitney test).
Howangyin et al  Efferocytosis and Cardiac Remodeling  835
survival. We found that peritoneal lavage fluid from WT mice 
transplanted with WT BM protects endothelial cells from 
apoptosis, in contrast to peritoneal lavage fluid from WT mice 
transplanted with Mertk−/−/Mfge8−/− BM. Concomitantly, peri-
toneal lavage fluid from WT mice transplanted with Mertk−/−/
Mfge8−/− BM decreases endothelial cell proliferation com-
pared with peritoneal lavage fluid from WT mice transplanted 
with WT BM (Figure 6C).
Taken together, these findings identify a role for Mertk- 
and Mfge8-dependent efferocytosis in promoting an M2 
phenotype and in controlling endothelial cell apoptosis and 
proliferation, at least in part, through the release of VEGFA 
by macrophages.
Loss of Myeloid Cell–Derived VEGFA Precipitates 
Adverse Left Ventricular Remodeling After MI
We then hypothesized that loss of myeloid-derived VEGF 
should recapitulate the effect of Mertk/Mfge8 deficiency 
on cardiac function and remodeling after MI. We used mice 
with both alleles of exon 3 of VEGFA flanked by loxP sites 
(VEGFfl/fl) crossed onto a background of Cre recombinase 
expression driven by the lysozyme M promoter (LysMCre+/
VEGFfl/fl).33 BM from LysMCre+/VEGFfl/fl mice was then 
transplanted into lethally irradiated WT animals. We con-
firmed the selective loss of VEGFA in the BM of LysMCre+/
VEGFfl/fl chimeras by quantitative polymerase chain reaction 
(Figure VIA in the online-only Data Supplement). VEGFA 
deletion was also established in BM-derived macrophages 
from these mice polarized toward an M1 or an M2 activation 
mode (Figure VIB in the online-only Data Supplement). At 
baseline, no differences in cardiac function, collagen con-
tent, and number of capillaries were observed in LysMCre+/
VEGFfl/fl chimeras compared with WT chimeras (Figure VIC 
in the online-only Data Supplement). After the ischemic 
insult, deletion of VEGF in myeloid cells resulted in lower 
ejection fraction (P<0.05) and enlarged left ventricular end-
systolic volumes (P<0.05) compared with WT mice receiv-
ing LysMCre−/VEGFAfl/fl BM (Figure 7A). These effects were 
associated with superior infarct size and collagen content and 
a limited number of capillaries in the infarcted hearts of mice 
reconstituted with VEGF-deficient myeloid cells (Figure 7B).
We highlighted that Mertk/Mfge8–related pathways trig-
gered an M2 activation mode in BM-derived macrophages. We 
postulated that VEGFA deletion in BM-derived macrophages 
might mimic this phenotype. To examine this hypothesis, mac-
rophages were differentiated in vitro from cultured BM isolated 
from LysMCre−/VEGFfl/fl or LysMCre+/VEGFfl/fl animals and 
activated with LPS+IFNγ, IL-4, or IL-10. M1 markers were 
strongly expressed in LPS+IFNγ–treated LysMCre+/VEGFfl/fl 
BM–derived macrophages compared with control (Figure 8A). 
Conversely, in the setting of IL-4 stimulation, mRNA levels of 
the M2 markers were downregulated in LysMCre+/VEGFfl/fl 
BM–derived macrophages compared with control cells 
(Figure 8B). In addition, we evaluated the phagocytosis capac-
ity of these macrophages in an in vivo efferocytosis assay 
(Figure 8C). Monocytes/macrophages harvested from perito-
neal lavage fluid from WT mice transplanted with LysMCre+/
VEGFfl/fl BM and challenged with apoptotic cells showed an 
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amount of efferocytosis similar to that of WT mice transplanted 
with LysMCre−/VEGFfl/fl BM. In contrast, apoptotic cells did not 
stimulate VEGFA release in peritoneal lavage fluid harvested 
from WT mice transplanted with LysMCre+/VEGFfl/fl BM.
Discussion
It is now widely accepted that cardiac remodeling after MI and 
myeloid cells are intertwined, yet the molecular mechanisms 
that link monocytes/macrophages to cardiac homeostasis are 
not well defined. Our results show that efficient Mertk- and 
Mfge8-dependent clearance of dying cardiac cells by tissue 
monocytes/macrophages dictates their phenotypes and is criti-
cal to the fine-tuning of the reparative process after ischemic 
cardiac injury. In particular, efferocytosis-related signaling 
commands VEGFA release by monocytes/macrophages to 
locally repair the dysfunctional heart.
A number of efferocytosis receptors have been identified in 
macrophages, suggesting that multiple complementary path-
ways are involved in the efficient clearance of apoptotic cells. 
Mertk deficiency alone has already been shown to increase the 
accumulation of apoptotic cardiomyocytes and compromises 
systolic performance of the infarcted heart.34 We provide the 
first evidence that Mfge8 is also engaged in the recognition of 
dying cells and in the control of cardiac function and remodel-
ing after MI. Mfge8 is known to link phosphatidylserine of 
dying cells to integrin α
v
β3 and αvβ5 of phagocytic cells.11–13 
Mfge8 supplementation strongly increases efferocytosis by 
WT and Mertk-deficient retinal pigment epithelium,13 imply-
ing that Mfge8-related signaling may constitute a nonredun-
dant pathway for the clearance of apoptotic cells. However, 
coexpression of the active form of Mertk with integrin α
v
β5 
has a synergistic effect on Rac1 activation, lamellipodia for-
mation, and the phagocytosis of apoptotic cells. Gas6 fails to 
stimulate phagocytosis in β5-deficient cells, suggesting that 
Mertk is directionally and functionally linked to the Mfge8/
integrin pathway to amplify intracellular signals and to inter-
nalize apoptotic cells.35 In addition, whereas Mertk is broadly 
expressed by all the different macrophage subpopulations, 
Mfge8 is essential for the phagocytosis of apoptotic cells by 
inflammation-activated macrophages.11,36 Although the direct 
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Figure 7. Loss of myeloid cell–derived vascular endothelial growth factor A (VEGFA) precipitates adverse left ventricular remodeling after 
myocardial infarction (MI). A, Echocardiographic analysis 14 days after MI. Ejection fraction (%), left ventricular end-diastolic volume (μL), 
and left ventricular end-systolic volume (μL) are shown for wild-type (WT) mice (Host) transplanted with bone marrow (BM)–derived cells 
isolated from LysMCre−VEGFfl/fl or LysMCre+VEGFfl/fl mice. Results are minimum to maximum values. n=7 to 8 mice per group. *P<0.05 
vs WT LysMCre−VEGFfl/fl chimeras (Mann–Whitney test). B, Quantitative analysis of infarct size, collagen content, number of apoptotic 
cells, and capillary density. Results are presented as scatterplots with mean bar. n=7 to 12 mice per group. *P<0.05, ***P<0.001 vs WT 
LysMCre−VEGFfl/fl chimeras (Mann–Whitney test).
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or indirect interactions between Mertk and Mfge8 signaling 
remain to be elucidated, our results clearly indicate that these 
2 major phagocytic proteins coordinately participate in tissue 
homeostasis and recovery from ischemic injury.
Cardiac monocyte and macrophage subsets have been 
shown to control tissue homeostasis through distinct properties. 
An inflammatory phenotype (Ly6CHigh monocytes/M1-type 
macrophages) initially governs robust inflammation, proteoly-
sis of the extracellular matrix, and clearance of dead cells, a 
prerequisite for replacing the infarcted milieu with granulation 
tissue. During the following phase, cells with a lesser inflamma-
tory phenotype (Ly6CInt/Low monocytes/M2-type macrophages) 
dominate and are thought to release VEGF and TGFβ, support-
ing angiogenesis and collagen production.15,17 In our experi-
ments, Mertk and Mfge8 deletion in BM had no effect on the 
tissue levels of the major chemoattractant molecules, on the 
recruitment of circulating inflammatory cells, on the accumula-
tion of monocytes, and on the number of circulating monocyte-
derived or tissue-resident macrophages within the ischemic 
myocardium. Hence, the pathophysiological outcome of Mertk 
and Mfge8 deletion was not related to a defective recruitment or 
accumulation of inflammatory cells but likely relied on mono-
cyte/macrophage skewing from an inflammatory to a reparative 
state. In vitro, Mertk and Mfge8 switch macrophages toward an 
M2-like mode and control the ability of IL-4– or IL-10–treated 
BM–derived macrophages to release VEGFA. Along this line, 
we unveiled a role for IL-4 activation in promoting the expres-
sion of both Mertk and Mfge8 in cultured BM-derived macro-
phages, potentially initiating a positive feedback loop to sustain 
an M2-like phenotype. Mertk- and Mfge8-dependent engulf-
ment of apoptotic cells commands VEGFA release by targeted 
monocytes/macrophages and shapes endothelial cells prolifera-
tion and apoptosis. Therefore, it is tempting to speculate that 
efficient Mertk- and Mfge8-dependent efferocytosis partici-
pates in the transition of cardiac phagocytes from an inflamma-
tory to a VEGFA-related reparative phenotype. However, one 
cannot refute the hypothesis that Mertk and Mfge8 concomitant 
loss may affect other protective mediators. 
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Figure 8. Loss of myeloid cell–derived vascular endothelial growth factor A (VEGFA) activates an M1 phenotype. cDNA from bone marrow 
(BM)–derived macrophages from LysMCre−VEGFfl/fl and LysMCre+VEGFfl/fl mice were analyzed by reverse transcription–quantitative 
polymerase chain reaction. A, mRNA levels for the markers of the M1-like mode: NOS2 and cox2. B, mRNA levels for the markers of the 
M2-like mode: Ym1, Arg1, VCAM-1, and RELMα. Results are mean±SEM. n=4 to 6 mice per group. *P<0.05, **P<0.01 vs LysMCre−VEGFfl/fl of 
the same stimulated group of macrophages (Mann–Whitney test). C, Apoptotic thymocytes were injected in wild-type (WT) mice transplanted 
with LysMCre−VEGFfl/fl or LysMCre+VEGFfl/fl BM. Peritoneal lavage fluid was harvested 3 hours after injection. Left, Amount of efferocytosis by 
monocytes/macrophages (CD45+/CD11b+/Ly6G-). Right, VEGFA protein levels from the supernatant of peritoneal lavage fluid. Results are 
mean±SEM. n=2 to 3 mice per group. (Mann–Whitney test). IFNγ indicates interferon-γ; IL, interleukin; and LPS, lipopolysaccharide.
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Interestingly, we showed that myeloid cell–derived 
VEGFA plays an essential role in cardiac function and remod-
eling, likely through activation of the angiogenic process in 
the border of the infarcted area. Several experimental reports 
demonstrated the proangiogenic activity of VEGF administra-
tion and its associated benefit on cardiac function in different 
models of MI.37 However, the net effect of myeloid-derived 
VEGFA in the reparative process after cardiac ischemic injury 
was still unexplored. Our results are in line with the role of 
myeloid-derived VEGF in other disease settings. In a model 
of pulmonary fibrosis in mice, deletion of VEGFA in myeloid 
cells reduced the formation of blood vessels and aggravated 
fibrotic tissue damage.33 Remarkably, VEGFA also modu-
lates the expression of a major actor of the proteolytic pro-
cess expressed by endothelial sinusoidal cells and regulates 
the fibrotic scar in the liver.38 Hence, myeloid cell–derived 
VEGF may be a critical regulator of extracellular matrix deg-
radation by cardiac endothelial cells, linking angiogenesis and 
fibrosis in the cardiac tissue. Consistent with this, we showed 
that specific ablation of VEGFA in myeloid cells decreased 
the number of capillaries but raised the collagen content in 
the infarcted heart. Nonetheless, BM-derived macrophages 
from LysMCre+/VEGFfl/fl displayed a proinflammatory phe-
notype, adjoining further complexity to the intrinsic crosstalk 
between VEGFA and macrophages. Along this line, VEGFA 
has been shown to induce multiple phenotypic and functional 
changes in infiltrated Ly6Chi monocytes, endowing them with 
enhanced proangiogenic and proarteriogenic capabilities.39
With respect to translation to the clinics, our results are 
promising, indicating that the modulation of phagocytic activ-
ity by recruited or resident cardiac macrophages may counter-
act adverse left ventricular remodeling. Notably, the strategy 
of using autologous apoptotic cells, that is, to improve effe-
rocytosis by reparative phagocytes, has even been clinically 
tested in patients with chronic heart failure.40 More interest-
ing, intravenous injection of phosphatidylserine-presenting 
liposomes is associated with activation of angiogenesis, pres-
ervation of small scars, and prevention of ventricular dilata-
tion and remodeling in a rat model of acute MI.41 Our work 
suggests that targeting local factors that promote myeloid 
cell–derived efferocytosis such as the Mertk/Mfge8 axis may 
counteract the local mediators of inflammation that drive car-
diac dysfunction and maladaptation after MI.
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CLINICAL PERSPECTIVE
Efficient efferocytosis, the process by which apoptotic or necrotic cells are actively removed out of the milieu, is critical to 
sustain tissue homeostasis by directing the healing of injured tissues. As a consequence, improper clearance of dying cells by 
activated neighboring phagocytes contributes to the establishment and progression of numerous human diseases. In infarcted 
heart, alteration of efferocytosis and ineffective elimination of dying cells by galvanized cardiac monocytes/macrophages 
may precipitate the transition to heart failure. We analyzed the coordinated role of 2 major mediators of efferocytosis, the 
myeloid-epithelial-reproductive protein tyrosine kinase (Mertk) and the milk fat globule epidermal growth factor (Mfge8), 
in directing cardiac remodeling by skewing the inflammatory response after myocardial infarction. We showed that Mertk- 
and Mfge8-expressing monocyte/macrophages synergistically engage the clearance of injured cardiomyocytes, favoring the 
secretion of the proangiogenic and antifibrotic vascular endothelial growth factor to locally repair the dysfunctional heart. 
With respect to translation into the clinics, our results are promising, indicating that the modulation of phagocytic activity by 
recruited or resident cardiac macrophages may counteract adverse left ventricle remodeling. In particular, our work suggests 
that targeting local factors that promote myeloid cell–derived efferocytosis such as the Mertk/Mfge8 axis may counteract the 
local mediators of inflammation that drive cardiac dysfunction and maladaptation after myocardial infarction.
